Dong-A ST back to 10%... Boryung PharmaceuticalㆍWhanin Pharmaceutical return to 5% shareholders
The National Pension Service (NPS) has again sold a large stake in pharmaceutical companies.
Earlier, the National Pension Service expanded pharmaceutical companies’ stake until the first half of last year but lowered its stake significantly in the second half.
In the first quarter, the National Pension Service’s ownership of pharmaceutical companies decreased sharply. During this period, the ownership in five pharmaceutical companies were reduced by more than 1%p.
According to the National Pension Service’s quarterly report on Stocks, etc. Held in Bulk, HanAll Biopharma’s stake in NPS plunged 3.04%p from 13.35% to 10.31% in 1Q.
Chong Kun Dang Pharmaceutical fell 2.09%p from 11.44% to 9.35%, and Handok dropped 2.06%p from 10.76% to 8.70%, down to a single digit.
JW Lifescience’s share of NPS also decreased by 2%p from 10.41% to 8.43%, and Bukwang Pharmaceutical also reduced by more than 1%p from 8.18% to 7.06%.
On the other hand, Dong-A ST’s ownership increased 1.04%p from 9.27% to 10.31%.
While NPS’s stake in Hanmi Pharmaceutical rose more than 1%p to 7.85%, Whanin Pharmaceutical and Boryung Pharmaceutical returned to 5% stockholders to 6.10% and 5.12%.